Why are Trump’s new tariffs targeting EU and Mexico?
How did Bitcoin reach a record high again?
Why is Meta investing billions in AI infrastructure?
What caused Tesla’s Autopilot legal trial in Florida?
How will Walmart's water bottle recall impact sales?
Why is Starbucks mandating office return four days weekly?
What effect will Trump’s Patriot missile plan have on Ukraine?
FDA Delays Approval For Ultragenyx's Gene Therapy, But Not A Dealbreaker, Says Analyst
benzinga.com/news/fda/25/07/46399211/fda-delays-approval-for-ultragenyxs-gene-therapy-but-not-a-dealbreaker-says-analyst
The U.S. Food and Drug Administration issued on Friday a Complete Response Letter for Ultragenyx Pharmaceutical Inc.’s (NASDAQ:RARE) Biologics License Application (BLA) for UX111 (ABO-102) AAV gene therapy for Sanfilippo syndrome type A (MPS IIIA).
In the CRL, the FDA requested that the…
This story appeared on benzinga.com, 2025-07-14 17:05:53.